Marginal Papular Acrokeratodermas: Classification

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Acral papular eruption.

On examination, there were multiple skin colored to erythematous and edematous papules of about 1 to 5 mm size [Figure 1]. Many of the lesions, located over the extensor aspects of hands [Figure 2], forearms, elbows and upper arms were topped with tiny crusts and scales whereas others showed a central dusky hue. Examination of the conjunctiva revealed mild icterus. Bilateral axillary, epitrochl...

متن کامل

Diffuse, pruritic, papular rash.

Volume 88, Number 9 www.aafp.org/afp American Family Physician 605 A 34-year-old man presented with a pruritic, erythematous, papular rash that appeared two days earlier. The rash started on his trunk and back, then progressed to his arms and the proximal portion of his legs. He did not have pain, burning, or a tingling sensation. He did not have a fever or other systemic symptoms, and the revi...

متن کامل

Household papular urticaria.

BACKGROUND Papular urticaria often occurs after bites of insects such as mosquitoes, sandflies, bed bugs and fleas. Multiple bites and local pruritus are characteristic symptoms. Treatment is usually symptomatic and includes antihistamines and corticosteroids. The reappearance of the symptoms can be prevented by successful control of the parasite. OBJECTIVES To find the causative agent of pap...

متن کامل

Palifermin-associated papular eruption.

BACKGROUND Palifermin is a recombinant human keratinocyte growth factor that is used to reduce the duration and severity of oral mucositis in patients undergoing hematopoietic stem cell transplantation after myelotoxic therapy. Cutaneous adverse reactions associated with keratinocyte growth factor are reported to be rash, pruritus, and erythema. OBSERVATIONS After receiving palifermin followi...

متن کامل

Efalizumab-associated papular psoriasis.

BACKGROUND Efalizumab is a human anti-CD11a monoclonal antibody used in the treatment of patients with moderate to severe plaque psoriasis. Some of the patients develop new papular lesions during treatment, which are predominantly located in the flexural regions. OBSERVATION Four patients with recalcitrant psoriasis undergoing treatment with efalizumab presented with erythematous, partly scal...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Dermatology

سال: 1995

ISSN: 1018-8665,1421-9832

DOI: 10.1159/000246677